Appia Bio
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
570 Westwood Plz, Los Angeles, Californi...Website
www.appiabio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
2
3
2
2
About Appia Bio
Founded in 2020 and based in Los Angeles, CA, Appia Bio is an early stage biotechnology company focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients.Explore more
Appia Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Appia Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Appia Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Appia Bio
Check if Appia Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Appia Bio is spiking on competitors!
Appia Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Appia Bio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Appia Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Appia Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Appia Bio as Masked Content
Find more new buyers
Compare Similar Companies to Appia Bio
Compare insights from companies similar to Appia Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Appia Bio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Appia Bio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Appia Bio.
Appia Bio financials insights
Gather financial insights about Appia Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$52M
Appia Bio Tech Stack
A closer look at the technologies used by Appia Bio
See more technologies
Most Recent Scoops
New Hire
Executive Move
New Hire
Executive Move
Open Position
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Appia Bio News & Media
Appia Bio Announces Appointment of Robert S. Negrin, M.D., to Scientific Advisory Board
LOS ANGELES, Dec. 15, 2022 /PRNewswire/ -- Appia Bio, Inc., a preclinical-stage biotechnology company developing allogeneic chimeric antigen receptor natural killer T (CAR-NKT) cell therapies for cancer patients, today announced the appointment of Robert S. Negrin, M.D., to its Scientific...Appia Bio Appoints Margo Roberts, Ph.D. to its Board of Directors and Names Jason Damiano, Ph.D. as Chief Scientific Officer
Dr. Roberts is a leading pioneer and accomplished research executive in cellular therapeutics Dr. Damiano brings more than 20 years' research experience in cancer biology, new target identification, and drug discovery LOS ANGELES, Aug. 9, 2022 /PRNewswire/ -- Appia Bio, Inc., a...Global Cancer Stem Cells Market Estimated to Surpass $1,722.7 Million by 2026, and Grow at a CAGR of 10.3% during the Forecast Period [180-Pages] | Confirmed by Research Dive
The global cancer stem cells market is projected to observe striking growth over the forecast period, due to the rising prevalence of cancer among people around the world. By cancer form, the breast sub-segment is predicted to observe significant growth by 2026. Geographically, the North America region is estimated to dominate during the analysis period. The global cancer stem cells market is projected to observe striking growth over the forecast period, due to the risingAppia Bio Announces Appointment of Irving Weissman, MD, and Mark Exley, PhD, to Scientific Advisory Board
LOS ANGELES, Dec. 2, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced the appointment of Irving Weissman, MD, and Mark Exley, PhD, to its...
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Appia Bio
Sign Up For FreeTo access detailed company insights
Founded in 2020 and based in Los Angeles, CA, Appia Bio is an early stage biotechnology company focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients.... Read More
